Real-Time PCR (qPCR) Market Size Set to Reach USD 10.30 Billion by 2032, with 4.67% CAGR – SNS Insider

According to Research by SNS Insider, Global qPCR Market Growth is Driven by Increasing Demand for Advanced Diagnostics in Genetic and Infectious Diseases.

Austin, Oct. 23, 2024 (GLOBE NEWSWIRE) — Real-Time PCR Market Size Analysis:

According to SNS Insider, The Real-Time PCR (qPCR) Market Size was estimated at USD 6.84 billion in 2023 and is expected to reach USD 10.30 billion by 2032, growing at a CAGR of 4.67% during the forecast period of 2024-2032. Such growth can be mainly attributed to the rising instances of genetic diseases, lethal infectious diseases, and the advancements in PCR technologies that can diagnose early and implement personalized therapies.

 

Real-Time PCR Market Trends

Real-time PCR is witnessing tremendous growth primarily due to the increased requirement for rapid and accurate diagnoses within clinics and research laboratories. The progressive nature of genetic diseases, infectious diseases, and cancer has enhanced the need for qPCR across various industries. This diagnostic technique provides fast and quantitative results, making it an indispensable one in healthcare.

Completion of the human genome project has opened up new avenues in the application of qPCR for biomarker profiling and personalized medicine, which further drives market demand. The COVID-19 pandemic brought into sharp focus the pivotal role that qPCR needs to play in detecting SARS-CoV-2 infections, further raising its profile and adoption. The supply chain for qPCR technologies is sound and characterized by steady inputs of reagents, instruments, and software solutions from major players. The market, however, presents challenges in terms of a cost barrier that comes with qPCR instruments, the necessity of well-trained professionals to handle complex systems, technological constraints involved in sample processing, and strict adherence to regulatory compliance. Despite these challenges, research and development in qPCR technology are underway and hold the promise of creating new opportunities. Automation along with advanced data analytics will better manage laboratory workflows, thus raising the total efficiency of diagnostic processes.

Get a Sample Report of Real-Time PCR (QPCR) Market@ https://www.snsinsider.com/sample-request/2573

Key Companies in the Real-Time PCR (qPCR) Market Include

• Abbott
• QIAGEN
• Bio-Rad Laboratories Inc.
• Agilent Technologies Inc.
• Thermo Fisher Scientific Inc.
• GE Healthcare
• bioMérieux
• F. Hoffmann-La Roche Ltd
• Fluidigm Corporation
• Takara Bio Inc.
• TOYOBO Inc.
• Lumex Instruments
• Analytik Jena AG
• Primerdesign Ltd
• B.D. and other players

Real-Time PCR (QPCR) Market Report Scope:

Report Attributes	Details
Market Size in 2023	US$ 6.84 Billion
Market Size by 2032	US$ 10.30 Billion
CAGR	CAGR of 4.67% From 2024 to 2032
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020-2022
Key Regional Coverage	North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)

Real-Time PCR (qPCR) Market Segment Insights

By Product:

Reagents & Consumables have emerged as the leading product area in the real-time PCR (qPCR) market in 2023, accounting for more than 55.0% of the overall market. This popularity is attributed to the regular and repeated consumable usage during qPCR testing. The growing application of qPCR in routine diagnostic testing has contributed to increasing demand for reagents and this is because they form the products that are indispensable for results to be accurate; hence, are must-haves in clinics and research facilities. In addition, increasing attention to personalized medicine and the discovery of biomarkers will further expedite the growth of this specialized reagent demand.

By Application:

Clinical applications accounted for more than 60.0% of the market share in 2023. The above factors can be ascribed to the growing incidence of infectious diseases, genetic disorders, and cancers due to significantly more consumption of qPCR technology in clinical diagnostics. High accuracy, sensitivity, and the pace with which qPCR identifies and measures pathogens and genetic mutations have made it an important tool in the provision of healthcare. The growing trend for early detection and personalized treatment methods further points to the continued market domination of qPCR in clinical applications.

By End-User:

Hospitals & Diagnostic Centers accounted for the majority in terms of market share, capturing more than 40.0% of the market in 2023. The adoption of qPCR technologies in hospitals and diagnostic labs has been driven by the continued management of infectious diseases and chronic illnesses wherein true and fast diagnostic solutions are highly demanded. Hospitals and diagnostic laboratories around the world are embracing qPCR as it allows seamless integration into clinical diagnostic workflows without posing any type of inconvenience. Demand for Time-artifacts diagnostics, particularly in emergency care and infectious disease control, would continue to drive this market segment.

Real-Time PCR (qPCR) Market Segmentation

By Product 

• Reagents & Consumables
• Instruments
• Software & Services

By Application 

• Clinical
• Research
• Forensics

By End-User 

• Hospitals &Diagnostic Centers
• Research Laboratories & Academic Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Research Organizations
• Forensic Laboratories

Do you have any specific queries or need any customization research on Real-Time PCR (QPCR) Market, Enquire Now@ https://www.snsinsider.com/enquiry/2573

Geographic Analysis

In 2023, North America dominated the league for this market of Real-Time PCR with a major share, due to their advanced healthcare infrastructure, major R&D investments, and dominance by some major industry players. The United States is ahead of most in terms of innovation in qPCR, with Thermo Fisher Scientific and Bio-Rad Laboratories leading the company in developing advanced qPCR technologies. The area’s focus on genomics research and personalized medicine has further contributed to the growth that has been witnessed in the applications of qPCR over time. Its increasingly routine use in laboratory practices and its role in public health initiatives, for which it has no alternatives, have kept North America at the top of the world’s map in the markets for qPCR.

Real-Time PCR (qPCR) Industry Developments

• Thermo Fisher Scientific, in February 2023 launched the QuantStudio 5 Real-Time PCR System aimed to provide greater accuracy and efficiency in genetic analysis.
• Bio-Rad Laboratories Inc. rolled out its SARS-CoV-2 ddPCR Kit in March 2023 which further boosted the firm’s options for accurate viral detection.
• QIAGEN launched the QIAcuity Digital PCR System in April 2023. It focuses on achieving quick and accurate outcomes in genetic studies.
• F. Hoffmann-La Roche Ltd introduced the LightCycler 96 System in June 2023. It was a highly advanced system primarily designed for high-throughput applications.
• Agilent Technologies, Inc. introduced the AriaMX Real-Time PCR System in August 2023. It emphasized more on streamlined workflow analysis and data processing.
• In September 2023, Fluidigm Corporation introduced its Advanta qPCR Assay. It has targeted applications in oncology and infectious disease applications.

Conclusion

The real-time PCR (qPCR) market will witness enormous growth in the coming future. Increased incidence of genetic disorders and infectious diseases, technological advancements, and the increasing use of qPCR across numerous industries are some of the factors that would help in the expansion of the above market. New automation, software solutions, and advanced data analytics will be the new frontier that will look at revolutionizing the market for industry players. With the growing demand for accurate, fast, and economical diagnostic solutions, this market of qPCR will remain a critical component of modern healthcare and research efforts.

Buy a Single-User PDF of Real-Time PCR (QPCR) Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/2573

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

• Incidence and Prevalence (2023)
• Prescription Trends, (2023), by Region
• Device Volume, by Region (2020-2032)
• Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023

6. Competitive Landscape

7. Real-Time PCR (QPCR) Market Segmentation, by Product

8. Real-Time PCR (QPCR) Market Segmentation, by Application

9. Real-Time PCR (QPCR) Market Segmentation, by End-User

10. Regional Analysis

11. Company Profiles

12. Use Cases and Best Practices

13. Conclusion

Request An Analyst Call@ https://www.snsinsider.com/request-analyst/2573

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: 
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)